Country Profile: Norway
Children aged 3 to 12 months
At-risk groups aged 2-64, including anatomical or functional splenic deficiency; cerebrospinal fluid leak; HIV/AIDS; B-cell deficiency; stem cell transplantation; haematological cancer (leukaemia, lymphoma and multiple myeloma); organ transplantation; cochlear implant; chronic liver disease; primary or congenital immunodeficiency condition; other cancers; chronic kidney disease; homeless and drug addicts; iatrogenic immunosuppression (except in case of organ transplantation); diabetes mellitus; celiac disease; reduced ventilation capacity; chronic lung disease; chronic heart disease; previously undergone pneumococcal pneumonia or IPD; alcoholism; smoking; occupational practice with increased risk
All people over the age of 65
Coverage figures (2021)
At-risk groups: –
Older adults: –
Norwegian Institute of Public Health: https://www.fhi.no/nettpub/vaksinasjonsveilederen-for-helsepersonell/vaksiner-mot-de-enkelte-sykdommene/pneumokokkvaksinasjon—veileder-fo/
Norwegian Institute of Public Health: https://www.fhi.no/sv/vaksine/bestilling/preparater-og-priser-/
At-risk groups: vaccination is recommended but must be purchased online with the approval of a doctor. The maximum retail price is NKr 344.40.
Older adults aged 65 and over: vaccination is recommended but not funded by the National Health system.